London’s Institute of Cancer Research has unveiled plans for a new global hub for cancer research and treatment

Major UK research institutions have outlined a twenty-year cancer research future for London. The London Cancer Hub is intended to become a world-leading life science campus that, according to plans published today, will potentially create 13,000 jobs and deliver at last two extra cancer drugs every five years.

The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, both organisations with an international reputation for cancer research and treatment, have partnered with the London Borough of Sutton to develop the Hub.

Professor Paul Workman, Chief Executive of The Institute of Cancer Research said “This is a fantastically exciting project to create the world’s leading cancer research campus here in London.” 

“The ICR and The Royal Marsden are already world leaders in cancer research and treatment, but by working with the London Borough of Sutton and the Greater London Authority, we aim to take our facilities and outputs to a new level. The ambition is to discover more innovative cancer drugs, to run more clinical trials, and to partner with industry to take even more treatments to patients.”

The development comes hot on the heels of London mayor, Boris Johnson’s ‘MedCity’ initiative, which aims to boost the life sciences sector in London and south east England. Supporting The London Cancer Hub, the Mayor said: “London is already a global capital of science and is awash with numerous exciting research institutions. The London Cancer Hub would be a real coup for the city and would help to ensure that the capital remains on the frontline of developing new treatments to cure the disease.”

The project will be funded through a combination of private investment, Government grants, philanthropy and commercial rental income. A full plan for the Sutton site, as well as improvements to local transport links, will be available for public consultation later this month.